Apollo Ap49 Limited
15508402
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
dormant
Next accounts due
30/09/2026
Confirmation statement
Last: 19/02/2026
Due 05/03/2027
Industry
Officers
director · Since 20/02/2024
CHIEF EXECUTIVE OFFICER
BRITISH · UNITED KINGDOM · Age 55
Also on 9 other boards
Persons with Significant Control
Apollo Therapeutics Limited
3rd Floor, 22 Station Road, Cambridge, CB1 2JD
Reg: 13396815 · Companies House · Limited By Shares
Notified 20/02/2024
CompanyRankvs 8104+ SIC 72190 peers23
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£1
Balance sheet strength
Cash
£1
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—